(Q40156496)

18 September 2017

1 reference

title

Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology (English)

1 reference

18 September 2017

1 reference

Schabel FM Jr

1

1 reference

18 September 2017

Griswold DP Jr

2

1 reference

18 September 2017

Laster WR Jr

4

1 reference

18 September 2017

F. M. Schabel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6351113

5 October 2023

D. P. Griswold

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6351113

5 October 2023

T. H. Corbett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6351113

5 October 2023

W. R. Laster

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6351113

5 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6351113

5 October 2023

publication date

1 January 1983

1 reference

full work available at URL

18 September 2017

https://api.elsevier.com/content/article/PII:0163725883900426?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

https://api.elsevier.com/content/article/PII:0163725883900426?httpAccept=text/plain

5 October 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Pharmacology & Therapeutics

5 October 2023

published in

1 reference

18 September 2017

20

1 reference

18 September 2017

2

1 reference

18 September 2017

283-305

1 reference

Relationship between plasma level and therapeutic effect of nortriptyline.

18 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Relationship Between the Plasma Level of Diphenylhydantoin Sodium and Its Cardiac Antiarrhythmic Effects

5 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD)

5 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Physicochemical and Biochemical Aspects of Pharmacology

5 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Phenylbutazone therapy; relation between the toxic and therapeutic effects and the blood level

5 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Favorable factors in the adjuvant therapy of breast cancer

5 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas

5 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy

5 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents

5 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

The Evolution of Therapeutic Research in Cancer

5 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer

5 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program

5 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Studies on the chemotherapy of the human malarias; method for the quantitative assay of suppressive antimalarial action in falciparum malaria

5 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

The practical benefits of pharmacokinetics in the use of antineoplastic agents

5 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Dose: a critical factor in cancer chemotherapy

5 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity

5 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

The serum level approach to individualization of drug dosage

5 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Procainamide dosage schedules, plasma concentrations, and clinical effects

5 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Some effects of cyclophosphamide (cytoxan) on normal mice and mice with L1210 leukemia

5 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity

5 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis

5 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia

5 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Patterns of Resistance and Therapeutic Synergism among Alkylating Agents1

5 October 2023

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity

5 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Studies on the chemotherapy of the human malarias; the antimalarial activity of quinacrine

5 October 2023

44

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Studies on the chemotherapy of the human malarias; the physiological disposition and antimalarial activity of the cinchona alkaloids

5 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance

5 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

Relation of hydralazine plasma concentration to dosage and hypotensive action

5 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

The basis for progress in chemotherapy

5 October 2023

49

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90042-6

5 October 2023

Identifiers

1 reference

18 September 2017

1 reference